Orica（ORI）株式概要オリカ・リミテッドは、オーストラリア、ペルー、カナダ、米国、および海外で、商業用発破システム、爆薬、採掘・トンネル掘削支援システム、各種化学製品・サービスを製造、販売、流通させている。 詳細ORI ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長3/6過去の実績5/6財務の健全性4/6配当金1/6報酬当社が推定した公正価値より59.7%で取引されている 収益は年間27.62%増加すると予測されています 過去1年間で収益は155.6%増加しました リスク分析多額の負債を抱えている すべてのリスクチェックを見るORI Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueAU$Current PriceAU$22.9721.9% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-1b9b2016201920222025202620282031Revenue AU$9.2bEarnings AU$282.8mAdvancedSet Fair ValueView all narrativesOrica Limited 競合他社Dyno NobelSymbol: ASX:DNLMarket cap: AU$6.7bMineral ResourcesSymbol: ASX:MINMarket cap: AU$12.6bSandfire ResourcesSymbol: ASX:SFRMarket cap: AU$8.8bBlueScope SteelSymbol: ASX:BSLMarket cap: AU$14.5b価格と性能株価の高値、安値、推移の概要Orica過去の株価現在の株価AU$23.0552週高値AU$26.4752週安値AU$18.59ベータ0.681ヶ月の変化5.49%3ヶ月変化16.18%1年変化20.62%3年間の変化51.59%5年間の変化63.59%IPOからの変化6.07%最新ニュースお知らせ • Jun 06Orica Limited Announces Appointment of Mark G. Johnson as Independent Non-Executive Director, Effective July 1, 2026Orica Limited announced the appointment of Mr. Mark G. Johnson as an Independent Non-executive Director of the Company, effective July 1, 2026. Mr. Johnson is a highly experienced company director and executive with extensive expertise in finance, audit, risk management, strategy development and execution, and human resource management. He has experience across various sectors, including engineering and construction, resources, industrial products, property, technology, retail and consumer goods as well as financial and professional services. Mr. Johnson is a Non-Executive Director of SGH Limited, Goodman Group, Aurecon Limited, Metcash Limited and Sydney Airport Limited. He is a Councillor at UNSW Sydney and the former Chairman of the Hospitals Contribution Fund of Australia. Mr. Johnson is a trained accountant and spent 30 years at PricewaterhouseCoopers (PwC) where he was CEO from 2008 to 2012 as well as holding positions as Asian Deputy-Chairman and as a member of PwC’s global strategy council. He was Chairman and a director of G8 Education Limited and was formerly an independent director of Coca Cola Amatil Limited, Westfield Corporation Limited and Boral Limited. Mr. Johnson holds a Bachelor of Commerce (UNSW) degree and is a Fellow of Chartered Accountants Australia and New Zealand, Certified Practicing Accountant Australia and Fellow of the Australian Institute of Company Directors.Declared Dividend • May 20First half dividend increased to AU$0.28Dividend of AU$0.28 is 14% higher than last year. Ex-date: 21st May 2026 Payment date: 3rd July 2026 Dividend yield will be 2.7%, which is lower than the industry average of 3.5%. Sustainability & Growth Dividend is not covered by earnings (114% earnings payout ratio). However, it is covered by cash flows (57% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 27% to bring the payout ratio under control. EPS is expected to grow by 92% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.Board Change • May 20Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 2 highly experienced directors. Chairman of the Board Vik Bansal was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Declared Dividend • May 09First half dividend increased to AU$0.28Dividend of AU$0.28 is 14% higher than last year. Ex-date: 21st May 2026 Payment date: 3rd July 2026 Dividend yield will be 2.8%, which is lower than the industry average of 3.5%. Sustainability & Growth Dividend is not covered by earnings (114% earnings payout ratio). However, it is covered by cash flows (57% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 27% to bring the payout ratio under control. EPS is expected to grow by 80% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.Reported Earnings • May 08First half 2026 earnings released: AU$0.001 loss per share (vs AU$0.18 loss in 1H 2025)First half 2026 results: AU$0.001 loss per share (improved from AU$0.18 loss in 1H 2025). Revenue: AU$3.90b (down 1.7% from 1H 2025). Net loss: AU$600.0k (loss narrowed 99% from 1H 2025). Profit margin: 0% (up from net loss in 1H 2025). The move to profitability was driven by lower expenses. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.Board Change • May 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 2 highly experienced directors. Chairman of the Board Vik Bansal was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.最新情報をもっと見るRecent updatesお知らせ • Jun 06Orica Limited Announces Appointment of Mark G. Johnson as Independent Non-Executive Director, Effective July 1, 2026Orica Limited announced the appointment of Mr. Mark G. Johnson as an Independent Non-executive Director of the Company, effective July 1, 2026. Mr. Johnson is a highly experienced company director and executive with extensive expertise in finance, audit, risk management, strategy development and execution, and human resource management. He has experience across various sectors, including engineering and construction, resources, industrial products, property, technology, retail and consumer goods as well as financial and professional services. Mr. Johnson is a Non-Executive Director of SGH Limited, Goodman Group, Aurecon Limited, Metcash Limited and Sydney Airport Limited. He is a Councillor at UNSW Sydney and the former Chairman of the Hospitals Contribution Fund of Australia. Mr. Johnson is a trained accountant and spent 30 years at PricewaterhouseCoopers (PwC) where he was CEO from 2008 to 2012 as well as holding positions as Asian Deputy-Chairman and as a member of PwC’s global strategy council. He was Chairman and a director of G8 Education Limited and was formerly an independent director of Coca Cola Amatil Limited, Westfield Corporation Limited and Boral Limited. Mr. Johnson holds a Bachelor of Commerce (UNSW) degree and is a Fellow of Chartered Accountants Australia and New Zealand, Certified Practicing Accountant Australia and Fellow of the Australian Institute of Company Directors.Declared Dividend • May 20First half dividend increased to AU$0.28Dividend of AU$0.28 is 14% higher than last year. Ex-date: 21st May 2026 Payment date: 3rd July 2026 Dividend yield will be 2.7%, which is lower than the industry average of 3.5%. Sustainability & Growth Dividend is not covered by earnings (114% earnings payout ratio). However, it is covered by cash flows (57% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 27% to bring the payout ratio under control. EPS is expected to grow by 92% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.Board Change • May 20Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 2 highly experienced directors. Chairman of the Board Vik Bansal was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Declared Dividend • May 09First half dividend increased to AU$0.28Dividend of AU$0.28 is 14% higher than last year. Ex-date: 21st May 2026 Payment date: 3rd July 2026 Dividend yield will be 2.8%, which is lower than the industry average of 3.5%. Sustainability & Growth Dividend is not covered by earnings (114% earnings payout ratio). However, it is covered by cash flows (57% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 27% to bring the payout ratio under control. EPS is expected to grow by 80% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.Reported Earnings • May 08First half 2026 earnings released: AU$0.001 loss per share (vs AU$0.18 loss in 1H 2025)First half 2026 results: AU$0.001 loss per share (improved from AU$0.18 loss in 1H 2025). Revenue: AU$3.90b (down 1.7% from 1H 2025). Net loss: AU$600.0k (loss narrowed 99% from 1H 2025). Profit margin: 0% (up from net loss in 1H 2025). The move to profitability was driven by lower expenses. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.Board Change • May 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 2 highly experienced directors. Chairman of the Board Vik Bansal was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Jan 05+ 2 more updatesOrica Limited, Annual General Meeting, Dec 16, 2026Orica Limited, Annual General Meeting, Dec 16, 2026.お知らせ • Jul 09Orica Limited Appoints Vik Bansal as Non-Executive Director and Chair ElectOrica Limited Chair, Malcolm Broomhead, announced the appointment of Vik Bansal to the Orica Limited Board as a Non-Executive Director, effective August 15, 2025. The Board has elected Mr. Bansal as Chair Elect, to assume the role at the completion of the 2025 Annual General Meeting. Vik Bansal is an experienced executive and non-executive director with over 30 years of experience managing complex industrial organisations. He is currently a non-executive director of Brambles Ltd. and Chair of LGI Limited, a clean energy company. Vik has held significant leadership roles in various industries where he led strategic growth and performance improvements, including CEO positions at Boral, InfraBuild, and Cleanaway, and global leadership roles at NYSE-listed Valmont Industries. Throughout his career, Vik has been recognised for his ability to drive shareholder returns through strategic and operational improvements. He has served on the boards of several organisations, including the National Waste & Recycling Industry Council and the Waste Management and Resource Recovery Association of Australia and not-for-profit Disability Services Australia. Vik is a Fellow of the Institute of Engineers Australia and the Australian Institute of Company Directors. Vik holds an Electrical Engineering degree with First Class Honors from NIT - Kurukshetra, an MBA from Deakin University, an Advanced Management Program from INSEAD, and a Master of Laws in Enterprise Governance.お知らせ • Mar 12Orica Limited (ASX:ORI) announces an Equity Buyback for AUD 400 million worth of its shares.Orica Limited (ASX:ORI) announces a share repurchase program. Under the program, the company will repurchase up to AUD 400 million worth of its shares. The program will be valid till March 27, 2026. As of March 12, 2025, the company had 487,360,505 issued shares.お知らせ • Jan 31Orica Limited Announces Executive ChangesOrica Limited announced that Erin O'Connor and Kirsten Anderson Llewellyn have each resigned as Company Secretary effective 31 January 2025. Krista Stewart has been appointed as Group General Counsel and Company Secretary, effective 31 January 2025, and will be the person responsible for communication with the ASX under Listing Rule 12.6.お知らせ • Jan 13+ 2 more updatesOrica Limited, Annual General Meeting, Dec 16, 2025Orica Limited, Annual General Meeting, Dec 16, 2025.Declared Dividend • Nov 16Final dividend increased to AU$0.28Dividend of AU$0.28 is 12% higher than last year. Ex-date: 22nd November 2024 Payment date: 23rd December 2024 Dividend yield will be 2.6%, which is lower than the industry average of 3.5%. Sustainability & Growth Dividend is covered by both earnings (42% earnings payout ratio) and cash flows (65% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 26% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • Nov 15Full year 2024 earnings released: EPS: AU$1.11 (vs AU$0.65 in FY 2023)Full year 2024 results: EPS: AU$1.11 (up from AU$0.65 in FY 2023). Revenue: AU$7.66b (down 3.6% from FY 2023). Net income: AU$524.6m (up 77% from FY 2023). Profit margin: 6.8% (up from 3.7% in FY 2023). Revenue is forecast to grow 4.5% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.Buy Or Sell Opportunity • Nov 12Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 2.2% to AU$17.46. The fair value is estimated to be AU$21.83, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 5.5% per annum. Earnings are also forecast to grow by 7.1% per annum over the same time period.Declared Dividend • May 11First half dividend increased to AU$0.19Dividend of AU$0.19 is 5.6% higher than last year. Ex-date: 23rd May 2024 Payment date: 3rd July 2024 Dividend yield will be 2.4%, which is lower than the industry average of 3.5%. Sustainability & Growth Dividend is well covered by both earnings (39% earnings payout ratio) and cash flows (36% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 23% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • May 10First half 2024 earnings released: EPS: AU$0.73 (vs AU$0.27 in 1H 2023)First half 2024 results: EPS: AU$0.73 (up from AU$0.27 in 1H 2023). Revenue: AU$3.66b (down 8.5% from 1H 2023). Net income: AU$337.5m (up 175% from 1H 2023). Profit margin: 9.2% (up from 3.1% in 1H 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.お知らせ • Feb 29Orica Limited Announces Retirement of Gene Tilbrook from the Board of DirectorsAs announced by Orica Chairman Malcolm Broomhead at the 2023 Annual General Meeting Mr. Gene Tilbrook has retired from the Board of Directors of Orica Limited, effective 29 February, 2024.New Risk • Feb 27New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 6.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Shareholders have been diluted in the past year (6.1% increase in shares outstanding).お知らせ • Feb 23Orica Limited has completed a Follow-on Equity Offering in the amount of AUD 400.000012 million.Orica Limited has completed a Follow-on Equity Offering in the amount of AUD 400.000012 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 25,252,526 Price\Range: AUD 15.84 Discount Per Security: AUD 0.2376 Transaction Features: Subsequent Direct Listingお知らせ • Feb 22+ 2 more updatesOrica Limited (ASX:ORI) entered into a binding agreement to acquire Cyanco Corporation from Cerberus Capital Management, L.P for the enterprise value of approximately $640 million.Orica Limited (ASX:ORI) entered into a binding agreement to acquire Cyanco Corporation from Cerberus Capital Management, L.P. for the enterprise value of approximately $640 million on February 21, 2024. The transaction will be financed with withdrawal from existing facility, balance sheet and institutional placement amount totaled $262.4 million. As of February 21, 2024, Cyanco reported the Net debt of approximately $665.3 million, total assets of approximately $545.2 million and EBITDA of $85 million. The acquisition is subject to the expiration of certain regulatory waiting periods and other customary closing conditions. The acquisition is expected to close by the end of FY2024. Morgan Stanley (NYSE:MS) acted as financial advisor to Cyanco Corporation.お知らせ • Jan 08+ 2 more updatesOrica Limited to Report First Half, 2024 Results on May 09, 2024Orica Limited announced that they will report first half, 2024 results on May 09, 2024お知らせ • Nov 11+ 1 more updateOrica Limited Provides Earnings Guidance for the Year 2024Orica Limited provided earnings guidance for the year 2024. The company’s 2024 financial year EBIT from continuing operations is expected to increase.Reported Earnings • Nov 09Full year 2023 earnings released: EPS: AU$0.65 (vs AU$0.35 in FY 2022)Full year 2023 results: EPS: AU$0.65 (up from AU$0.35 in FY 2022). Revenue: AU$7.95b (up 12% from FY 2022). Net income: AU$295.7m (up 104% from FY 2022). Profit margin: 3.7% (up from 2.0% in FY 2022). Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 8.5% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.お知らせ • Nov 02CF Industries Files a Separate Lawsuit in the United States Against OricaOrica announced that it is a joint plaintiff in a lawsuit filed in the United States on 21 October 2023 (US time) against CF Industries regarding contractual disputes under an ammonium nitrate purchase agreement for the supply of ammonium nitrate and related products for use by Orica's business across North America. CF Industries filed a separate lawsuit in the United States regarding contractual disputes of this agreement on 22 October 2023 (US time). Orica is pursuing its claims and defending CF Industries' claims while continuing to fully comply with its contractual obligations.Upcoming Dividend • May 18Upcoming dividend of AU$0.18 per share at 2.2% yieldEligible shareholders must have bought the stock before 25 May 2023. Payment date: 03 July 2023. Payout ratio is a comfortable 65% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of Australian dividend payers (7.3%). Lower than average of industry peers (5.7%).お知らせ • May 13Orica Limited Announces Distribution for the Six Months Ended March 31, 2023, Payable on July 3, 2023Orica Limited announced the Distribution of AUD 0.18000000 per share for the six months ended March 31, 2023, payable on July 3, 2023. Record Date is on May 26, 2023 and Ex date is on May 25, 2023.Reported Earnings • May 11First half 2023 earnings releasedFirst half 2023 results: EPS: AU$0.27. Revenue: AU$4.01b (up 31% from 1H 2022). Net income: AU$122.6m (up AU$122.6m from 1H 2022). Profit margin: 3.1% (up from 0% in 1H 2022). Revenue is forecast to stay flat during the next 3 years compared to a 11% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.お知らせ • Jan 18Orica Limited Announces Vanessa Guthrie AO as Independent, Non-Executive, Effective 1 February 2023Orica Limited announced the appointment of Dr. Vanessa Guthrie AO as independent, Non-Executive Director, to the Orica Board effective 1 February 2023. The appointment of Dr. Guthrie is part of the Orica Board's ongoing renewal process, following the retirement of Ms. Maxine Brenner and Mr. Boon Swan Foo at the conclusion of the 2022 Annual General Meeting and the previously announced appointment of Mr. Mark Garrett, effective 15 January 2023. Dr. Guthrie's broad and strategic experience in the resources sector started over 30 years ago in Australia with RGC Limited (Tasmania). Since then, Dr.Guthrie has held a diverse set of senior leadership roles across operations, environment, community, indigenous affairs and corporate development and sustainability. Previously Managing Director and CEO of ASX-listed Toro Energy Limited and private company Wellard Enterprises, Vice President Sustainable Development of Woodside Energy Limited, Huntly Mine Manager of Alcoa Australia and Chair of Minerals Council of Australia. Dr. Guthrie is Deputy Chair and Lead Independent Director of Adbri Limited, Non-Executive Director of Santos Limited, Tronox Holdings PLC and Lynas Rare Earths Limited, Non-Executive Director of Cricket Australia and Infrastructure Australia, and Pro-Chancellor of Curtin University. Dr. Guthrie's contribution to the mining and resources industry was recognised in 2017 with the award of an Honorary Doctor of Science from Curtin University. In 2021 she was also made an Officer of the Order of Australia. Dr. Guthrie is also a Fellow of the Australian Institute of Company Directors (FAICD), the Australian Academy of Technological Sciences and Engineering (FTSE) and the Australasian Institute of Mining and Metallurgy (FAusIMM). Dr. Guthrie has qualifications in geology, environment, law and business management, including a PhD in Geology.お知らせ • Dec 23+ 2 more updatesOrica Limited, Annual General Meeting, Feb 13, 2023Orica Limited, Annual General Meeting, Feb 13, 2023.Reported Earnings • Nov 10Full year 2022 earnings released: EPS: AU$0.35 (vs AU$0.46 loss in FY 2021)Full year 2022 results: EPS: AU$0.35 (up from AU$0.46 loss in FY 2021). Revenue: AU$7.13b (up 36% from FY 2021). Net income: AU$144.7m (up AU$333.1m from FY 2021). Profit margin: 2.0% (up from net loss in FY 2021). Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 7.1% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.Upcoming Dividend • May 24Upcoming dividend of AU$0.13 per shareEligible shareholders must have bought the stock before 31 May 2022. Payment date: 08 July 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 1.5%. Lower than top quartile of Australian dividend payers (6.1%). Lower than average of industry peers (1.9%).Reported Earnings • May 14First half 2022 earnings released: EPS: AU$0.002 (vs AU$0.18 in 1H 2021)First half 2022 results: EPS: AU$0.002 (down from AU$0.18 in 1H 2021). Revenue: AU$3.05b (up 26% from 1H 2021). Net income: AU$0 (down AU$73.7m from profit in 1H 2021). Profit margin: 0% (down from 3.0% in 1H 2021). Over the next year, revenue is forecast to grow 8.4%, compared to a 18% growth forecast for the industry in Australia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 90 percentage points per year, which is a significant difference in performance.お知らせ • May 13Orica Limited Announces Distribution for the Period of Six Months Ended 31 March 2022, Payable on July 08, 2022Orica Limited announced the distribution of AUD 0.13000000 per share for the period of six months ended 31 March 2022. The dividend will paid on July 08, 2022 with record date of June 01, 2022 and ex-date is May 31, 2022.お知らせ • Mar 28Orica Limited Appoints Gordon Naylor as Independent, Non-Executive Director, Effective 1 April 2022Orica Chairman Malcolm Broomhead announced the appointment of Mr. Gordon Naylor as independent, non-executive Director, effective 1 April 2022. Mr. Broomhead said that with Mr. Naylor's many years of global leadership experience at CSL, he will be a strong addition to the Board and complement the future strategy of the company. Mr. Naylor will offer himself for election as a Director at the next Annual General Meeting in December 2022. Starting his career as an engineer in the car manufacturing industry, Mr. Naylor then joined CSL, Australia's leading global biotech company. Over more than 30 years, Mr. Naylor held a range of business and functional leadership roles in international environments within CSL including as Chief Financial Officer for five years. At the time of his retirement from CSL, he was President of Seqirus where he had led the three-year turnaround of that business into the global influenza vaccines leader.Buying Opportunity • Mar 23Now 20% undervaluedOver the last 90 days, the stock is up 12%. The fair value is estimated to be AU$19.23, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 2.8% per annum over the last 3 years. The company became loss making over the last year.Recent Insider Transactions • Nov 17Independent Non-Executive Director recently bought AU$250k worth of stockOn the 15th of November, Boon Foo bought around 16k shares on-market at roughly AU$15.61 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$598k more in shares than they have sold in the last 12 months.Reported Earnings • Nov 13Full year 2021 earnings releasedThe company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2021 results: Revenue: AU$5.25b (down 6.7% from FY 2020). Net loss: AU$188.4m (down 212% from profit in FY 2020).Valuation Update With 7 Day Price Move • Oct 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to AU$14.01, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 32x in the Chemicals industry in Australia. Total loss to shareholders of 13% over the past three years.Recent Insider Transactions • Oct 02Independent Non-Executive Director recently bought AU$137k worth of stockOn the 30th of September, Denise Gibson bought around 10k shares on-market at roughly AU$13.68 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$348k more in shares than they have sold in the last 12 months.Upcoming Dividend • May 24Upcoming dividend of AU$0.075 per shareEligible shareholders must have bought the stock before 31 May 2021. Payment date: 09 July 2021. Trailing yield: 1.8%. Lower than top quartile of Australian dividend payers (5.2%). In line with average of industry peers (1.8%).Reported Earnings • May 14First half 2021 earnings released: EPS AU$0.19 (vs AU$0.43 in 1H 2020)The company reported a poor first half result with weaker earnings, revenues and profit margins. First half 2021 results: Revenue: AU$2.64b (down 8.7% from 1H 2020). Net income: AU$76.7m (down 54% from 1H 2020). Profit margin: 2.9% (down from 5.7% in 1H 2020). Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.お知らせ • May 13Orica Declares Interim Dividend for the Six Ended March 31, 2021, Payable on 9 July 2021Orica Board has declared an interim dividend on ordinary shares of 7.5 cents per share, unfranked. The dividend represents a payout ratio (17) of 42%. The dividend is payable to shareholders on 9 July 2021 and shareholders registered as at the close of business on 1 June 2021 will be eligible for the interim dividend.Executive Departure • Apr 09MD, CEO & Executive Director Alberto Zuleta has left the companyOn the 1st of April, Alberto Zuleta, was replaced as CEO by Sanjeev Gandhi. As of December 2020, Alberto personally held 268.40k shares (AU$4.1m worth at the time). A total of 2 executives have left over the last 12 months.Is New 90 Day High Low • Feb 27New 90-day low: AU$12.56The company is down 25% from its price of AU$16.84 on 27 November 2020. The Australian market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$23.24 per share.Valuation Update With 7 Day Price Move • Feb 27Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to AU$12.56, the stock is trading at a trailing P/E ratio of 29.5x, down from the previous P/E ratio of 35.2x. This compares to an average P/E of 30x in the Chemicals industry in Australia. Total return to shareholders over the past three years is a loss of 24%.お知らせ • Feb 26+ 1 more updateOrica Limited Announces Executive ChangesOrica Chairman Malcolm Broomhead announced that Alberto Calderon will step down from his role as CEO, after almost six years in the role. Orica's Group Executive and President of Australia Pacific Asia, Sanjeev Gandhi, has been appointed as the new CEO of Orica Limited. Mr. Gandhi joined Orica in July 2020 after spending 26 years with German chemical company BASF SE, the global leader in the chemical industry. During his tenure with BASF, he held senior marketing, commercial, business leadership and director roles, in India, Germany, Japan, Singapore and Hong Kong. Most recently, Mr. Gandhi was an Executive Director of BASF SE and Head of Asia Pacific as well as Head of Global Chemicals Segment (Intermediates & Petrochemicals) based out of Hong Kong.お知らせ • Jan 16Orica Limited, Annual General Meeting, Dec 16, 2021Orica Limited, Annual General Meeting, Dec 16, 2021.Recent Insider Transactions • Jan 14MD, CEO & Executive Director recently bought AU$130k worth of stockOn the 14th of January, Alberto Zuleta bought around 7k shares on-market at roughly AU$18.87 per share. This was the largest purchase by an insider in the last 3 months. Alberto has been a buyer over the last 12 months, purchasing a net total of AU$211k worth in shares.Is New 90 Day High Low • Jan 05New 90-day low: AU$14.92The company is down 10.0% from its price of AU$16.65 on 08 October 2020. The Australian market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$31.94 per share.Recent Insider Transactions • Dec 01Non-Executive Director recently bought AU$61k worth of stockOn the 24th of November, John Beevers bought around 4k shares on-market at roughly AU$17.00 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$141k more in shares than they have sold in the last 12 months.お知らせ • Nov 25+ 1 more updateOrica Limited to Report First Half, 2021 Results on May 13, 2021Orica Limited announced that they will report first half, 2021 results on May 13, 2021Reported Earnings • Nov 21Full year 2020 earnings released: EPS AU$0.42The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: AU$5.63b (down 4.5% from FY 2019). Net income: AU$168.3m (down 31% from FY 2019). Profit margin: 3.0% (down from 4.2% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.Analyst Estimate Surprise Post Earnings • Nov 21Revenue misses expectationsRevenue missed analyst estimates by 1.0%. Over the next year, revenue is forecast to grow 3.0%, compared to a 2.7% growth forecast for the Chemicals industry in Australia.Is New 90 Day High Low • Oct 31New 90-day low: AU$15.24The company is down 12% from its price of AU$17.29 on 31 July 2020. The Australian market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$26.66 per share.Is New 90 Day High Low • Sep 22New 90-day low: AU$15.74The company is down 6.0% from its price of AU$16.79 on 24 June 2020. The Australian market is flat over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$22.09 per share.株主還元ORIAU ChemicalsAU 市場7D-0.5%0.9%-1.6%1Y20.6%22.9%-0.4%株主還元を見る業界別リターン: ORI過去 1 年間で22.9 % の収益を上げたAustralian Chemicals業界を下回りました。リターン対市場: ORI過去 1 年間で-0.4 % の収益を上げたAustralian市場を上回りました。価格変動Is ORI's price volatile compared to industry and market?ORI volatilityORI Average Weekly Movement4.4%Chemicals Industry Average Movement11.1%Market Average Movement10.1%10% most volatile stocks in AU Market17.2%10% least volatile stocks in AU Market4.0%安定した株価: ORI 、 Australian市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: ORIの 週次ボラティリティ ( 4% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト187414,000Sanjeev Kumar Gandhiwww.orica.comオリカ・リミテッドはオーストラリア、ペルー、カナダ、米国、および海外で商業用発破システム、爆薬、採掘・トンネル掘削支援システム、各種化学製品・サービスを製造、流通、販売。4Dバルク爆薬システム、パッケージ爆薬、発火システム、ブースター、耐震爆薬レンジ、技術サービス、付帯サービスを提供。また、坑内開発装薬システム搭載機Avatel、遠隔発破ソリューションである二次破砕・ハングアップ発破などの自動化ソリューションも提供している。さらに、シアン化物、乳化剤、シアン化ナトリウムなどの鉱業用化学製品やPROサービス、発破プロセスの様々な段階におけるデジタル対応のベンチマークと洞察、尿素硝酸アンモニウムやアンモニアなどの窒素肥料も提供している。さらに、発破における化学エネルギーの使用、発破の基礎、火薬の特性と発破原理を探求するリソース、トレーニングコース、発破システム、地盤の変形と収束のモニタリングソリューションを提供している。さらに、BlastIQ、OREPro 3D、CHAMP NAVIGATOR、CHAMPORI、CHAMP OSA、FRAGTrack、GroundProbe、3vGeomatics、MEASURAND、NAVSTAR、rst、SYSCOM Instruments、NEXT GEN SHOTPlus、RHINO、DRILLMax、WIREBmr、ENVIRO Track、Integrated Extraction Simulator、Advanced Vibration Management、Axis mining technology、SHOTPlus、OREPro 3D Predict、Design for Outcomeなどのデジタルソリューションを提供している。同社は、地上石炭、地上金属、鉄鉱石、採石、地下採掘・建設、建築、土木インフラ、石油・ガス市場にサービスを提供している。旧社名はICIオーストラリア・リミテッドで、1998年2月にオリカ・リミテッドに社名変更。オリカ・リミテッドは1874年に設立され、本社はオーストラリアのイースト・メルボルンにある。もっと見るOrica Limited 基礎のまとめOrica の収益と売上を時価総額と比較するとどうか。ORI 基礎統計学時価総額AU$10.68b収益（TTM）AU$250.70m売上高(TTM)AU$8.12b42.6xPER（株価収益率1.3xP/SレシオORI は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計ORI 損益計算書（TTM）収益AU$8.12b売上原価AU$4.62b売上総利益AU$3.50bその他の費用AU$3.25b収益AU$250.70m直近の収益報告Mar 31, 2026次回決算日Nov 12, 2026一株当たり利益（EPS）0.54グロス・マージン43.11%純利益率3.09%有利子負債／自己資本比率76.7%ORI の長期的なパフォーマンスは？過去の実績と比較を見る配当金2.5%現在の配当利回り114%配当性向ORI 配当は確実ですか？ORI 配当履歴とベンチマークを見るORI 、いつまでに購入すれば配当金を受け取れますか？Orica 配当日配当落ち日May 21 2026配当支払日Jul 03 2026配当落ちまでの日数21 days配当支払日までの日数22 daysORI 配当は確実ですか？ORI 配当履歴とベンチマークを見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/10 16:40終値2026/06/10 00:00収益2026/03/31年間収益2025/09/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Orica Limited 14 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。31 アナリスト機関Brook Campbell-CrawfordBarrenjoey Markets Pty LimitedBenjamin BrayshawBarrenjoey Markets Pty LimitedJoseph HouseBell Potter28 その他のアナリストを表示
お知らせ • Jun 06Orica Limited Announces Appointment of Mark G. Johnson as Independent Non-Executive Director, Effective July 1, 2026Orica Limited announced the appointment of Mr. Mark G. Johnson as an Independent Non-executive Director of the Company, effective July 1, 2026. Mr. Johnson is a highly experienced company director and executive with extensive expertise in finance, audit, risk management, strategy development and execution, and human resource management. He has experience across various sectors, including engineering and construction, resources, industrial products, property, technology, retail and consumer goods as well as financial and professional services. Mr. Johnson is a Non-Executive Director of SGH Limited, Goodman Group, Aurecon Limited, Metcash Limited and Sydney Airport Limited. He is a Councillor at UNSW Sydney and the former Chairman of the Hospitals Contribution Fund of Australia. Mr. Johnson is a trained accountant and spent 30 years at PricewaterhouseCoopers (PwC) where he was CEO from 2008 to 2012 as well as holding positions as Asian Deputy-Chairman and as a member of PwC’s global strategy council. He was Chairman and a director of G8 Education Limited and was formerly an independent director of Coca Cola Amatil Limited, Westfield Corporation Limited and Boral Limited. Mr. Johnson holds a Bachelor of Commerce (UNSW) degree and is a Fellow of Chartered Accountants Australia and New Zealand, Certified Practicing Accountant Australia and Fellow of the Australian Institute of Company Directors.
Declared Dividend • May 20First half dividend increased to AU$0.28Dividend of AU$0.28 is 14% higher than last year. Ex-date: 21st May 2026 Payment date: 3rd July 2026 Dividend yield will be 2.7%, which is lower than the industry average of 3.5%. Sustainability & Growth Dividend is not covered by earnings (114% earnings payout ratio). However, it is covered by cash flows (57% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 27% to bring the payout ratio under control. EPS is expected to grow by 92% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.
Board Change • May 20Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 2 highly experienced directors. Chairman of the Board Vik Bansal was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Declared Dividend • May 09First half dividend increased to AU$0.28Dividend of AU$0.28 is 14% higher than last year. Ex-date: 21st May 2026 Payment date: 3rd July 2026 Dividend yield will be 2.8%, which is lower than the industry average of 3.5%. Sustainability & Growth Dividend is not covered by earnings (114% earnings payout ratio). However, it is covered by cash flows (57% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 27% to bring the payout ratio under control. EPS is expected to grow by 80% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.
Reported Earnings • May 08First half 2026 earnings released: AU$0.001 loss per share (vs AU$0.18 loss in 1H 2025)First half 2026 results: AU$0.001 loss per share (improved from AU$0.18 loss in 1H 2025). Revenue: AU$3.90b (down 1.7% from 1H 2025). Net loss: AU$600.0k (loss narrowed 99% from 1H 2025). Profit margin: 0% (up from net loss in 1H 2025). The move to profitability was driven by lower expenses. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.
Board Change • May 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 2 highly experienced directors. Chairman of the Board Vik Bansal was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Jun 06Orica Limited Announces Appointment of Mark G. Johnson as Independent Non-Executive Director, Effective July 1, 2026Orica Limited announced the appointment of Mr. Mark G. Johnson as an Independent Non-executive Director of the Company, effective July 1, 2026. Mr. Johnson is a highly experienced company director and executive with extensive expertise in finance, audit, risk management, strategy development and execution, and human resource management. He has experience across various sectors, including engineering and construction, resources, industrial products, property, technology, retail and consumer goods as well as financial and professional services. Mr. Johnson is a Non-Executive Director of SGH Limited, Goodman Group, Aurecon Limited, Metcash Limited and Sydney Airport Limited. He is a Councillor at UNSW Sydney and the former Chairman of the Hospitals Contribution Fund of Australia. Mr. Johnson is a trained accountant and spent 30 years at PricewaterhouseCoopers (PwC) where he was CEO from 2008 to 2012 as well as holding positions as Asian Deputy-Chairman and as a member of PwC’s global strategy council. He was Chairman and a director of G8 Education Limited and was formerly an independent director of Coca Cola Amatil Limited, Westfield Corporation Limited and Boral Limited. Mr. Johnson holds a Bachelor of Commerce (UNSW) degree and is a Fellow of Chartered Accountants Australia and New Zealand, Certified Practicing Accountant Australia and Fellow of the Australian Institute of Company Directors.
Declared Dividend • May 20First half dividend increased to AU$0.28Dividend of AU$0.28 is 14% higher than last year. Ex-date: 21st May 2026 Payment date: 3rd July 2026 Dividend yield will be 2.7%, which is lower than the industry average of 3.5%. Sustainability & Growth Dividend is not covered by earnings (114% earnings payout ratio). However, it is covered by cash flows (57% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 27% to bring the payout ratio under control. EPS is expected to grow by 92% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.
Board Change • May 20Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 2 highly experienced directors. Chairman of the Board Vik Bansal was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Declared Dividend • May 09First half dividend increased to AU$0.28Dividend of AU$0.28 is 14% higher than last year. Ex-date: 21st May 2026 Payment date: 3rd July 2026 Dividend yield will be 2.8%, which is lower than the industry average of 3.5%. Sustainability & Growth Dividend is not covered by earnings (114% earnings payout ratio). However, it is covered by cash flows (57% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 27% to bring the payout ratio under control. EPS is expected to grow by 80% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.
Reported Earnings • May 08First half 2026 earnings released: AU$0.001 loss per share (vs AU$0.18 loss in 1H 2025)First half 2026 results: AU$0.001 loss per share (improved from AU$0.18 loss in 1H 2025). Revenue: AU$3.90b (down 1.7% from 1H 2025). Net loss: AU$600.0k (loss narrowed 99% from 1H 2025). Profit margin: 0% (up from net loss in 1H 2025). The move to profitability was driven by lower expenses. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.
Board Change • May 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 2 highly experienced directors. Chairman of the Board Vik Bansal was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Jan 05+ 2 more updatesOrica Limited, Annual General Meeting, Dec 16, 2026Orica Limited, Annual General Meeting, Dec 16, 2026.
お知らせ • Jul 09Orica Limited Appoints Vik Bansal as Non-Executive Director and Chair ElectOrica Limited Chair, Malcolm Broomhead, announced the appointment of Vik Bansal to the Orica Limited Board as a Non-Executive Director, effective August 15, 2025. The Board has elected Mr. Bansal as Chair Elect, to assume the role at the completion of the 2025 Annual General Meeting. Vik Bansal is an experienced executive and non-executive director with over 30 years of experience managing complex industrial organisations. He is currently a non-executive director of Brambles Ltd. and Chair of LGI Limited, a clean energy company. Vik has held significant leadership roles in various industries where he led strategic growth and performance improvements, including CEO positions at Boral, InfraBuild, and Cleanaway, and global leadership roles at NYSE-listed Valmont Industries. Throughout his career, Vik has been recognised for his ability to drive shareholder returns through strategic and operational improvements. He has served on the boards of several organisations, including the National Waste & Recycling Industry Council and the Waste Management and Resource Recovery Association of Australia and not-for-profit Disability Services Australia. Vik is a Fellow of the Institute of Engineers Australia and the Australian Institute of Company Directors. Vik holds an Electrical Engineering degree with First Class Honors from NIT - Kurukshetra, an MBA from Deakin University, an Advanced Management Program from INSEAD, and a Master of Laws in Enterprise Governance.
お知らせ • Mar 12Orica Limited (ASX:ORI) announces an Equity Buyback for AUD 400 million worth of its shares.Orica Limited (ASX:ORI) announces a share repurchase program. Under the program, the company will repurchase up to AUD 400 million worth of its shares. The program will be valid till March 27, 2026. As of March 12, 2025, the company had 487,360,505 issued shares.
お知らせ • Jan 31Orica Limited Announces Executive ChangesOrica Limited announced that Erin O'Connor and Kirsten Anderson Llewellyn have each resigned as Company Secretary effective 31 January 2025. Krista Stewart has been appointed as Group General Counsel and Company Secretary, effective 31 January 2025, and will be the person responsible for communication with the ASX under Listing Rule 12.6.
お知らせ • Jan 13+ 2 more updatesOrica Limited, Annual General Meeting, Dec 16, 2025Orica Limited, Annual General Meeting, Dec 16, 2025.
Declared Dividend • Nov 16Final dividend increased to AU$0.28Dividend of AU$0.28 is 12% higher than last year. Ex-date: 22nd November 2024 Payment date: 23rd December 2024 Dividend yield will be 2.6%, which is lower than the industry average of 3.5%. Sustainability & Growth Dividend is covered by both earnings (42% earnings payout ratio) and cash flows (65% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 26% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • Nov 15Full year 2024 earnings released: EPS: AU$1.11 (vs AU$0.65 in FY 2023)Full year 2024 results: EPS: AU$1.11 (up from AU$0.65 in FY 2023). Revenue: AU$7.66b (down 3.6% from FY 2023). Net income: AU$524.6m (up 77% from FY 2023). Profit margin: 6.8% (up from 3.7% in FY 2023). Revenue is forecast to grow 4.5% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
Buy Or Sell Opportunity • Nov 12Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 2.2% to AU$17.46. The fair value is estimated to be AU$21.83, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 5.5% per annum. Earnings are also forecast to grow by 7.1% per annum over the same time period.
Declared Dividend • May 11First half dividend increased to AU$0.19Dividend of AU$0.19 is 5.6% higher than last year. Ex-date: 23rd May 2024 Payment date: 3rd July 2024 Dividend yield will be 2.4%, which is lower than the industry average of 3.5%. Sustainability & Growth Dividend is well covered by both earnings (39% earnings payout ratio) and cash flows (36% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 23% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • May 10First half 2024 earnings released: EPS: AU$0.73 (vs AU$0.27 in 1H 2023)First half 2024 results: EPS: AU$0.73 (up from AU$0.27 in 1H 2023). Revenue: AU$3.66b (down 8.5% from 1H 2023). Net income: AU$337.5m (up 175% from 1H 2023). Profit margin: 9.2% (up from 3.1% in 1H 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
お知らせ • Feb 29Orica Limited Announces Retirement of Gene Tilbrook from the Board of DirectorsAs announced by Orica Chairman Malcolm Broomhead at the 2023 Annual General Meeting Mr. Gene Tilbrook has retired from the Board of Directors of Orica Limited, effective 29 February, 2024.
New Risk • Feb 27New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 6.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Shareholders have been diluted in the past year (6.1% increase in shares outstanding).
お知らせ • Feb 23Orica Limited has completed a Follow-on Equity Offering in the amount of AUD 400.000012 million.Orica Limited has completed a Follow-on Equity Offering in the amount of AUD 400.000012 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 25,252,526 Price\Range: AUD 15.84 Discount Per Security: AUD 0.2376 Transaction Features: Subsequent Direct Listing
お知らせ • Feb 22+ 2 more updatesOrica Limited (ASX:ORI) entered into a binding agreement to acquire Cyanco Corporation from Cerberus Capital Management, L.P for the enterprise value of approximately $640 million.Orica Limited (ASX:ORI) entered into a binding agreement to acquire Cyanco Corporation from Cerberus Capital Management, L.P. for the enterprise value of approximately $640 million on February 21, 2024. The transaction will be financed with withdrawal from existing facility, balance sheet and institutional placement amount totaled $262.4 million. As of February 21, 2024, Cyanco reported the Net debt of approximately $665.3 million, total assets of approximately $545.2 million and EBITDA of $85 million. The acquisition is subject to the expiration of certain regulatory waiting periods and other customary closing conditions. The acquisition is expected to close by the end of FY2024. Morgan Stanley (NYSE:MS) acted as financial advisor to Cyanco Corporation.
お知らせ • Jan 08+ 2 more updatesOrica Limited to Report First Half, 2024 Results on May 09, 2024Orica Limited announced that they will report first half, 2024 results on May 09, 2024
お知らせ • Nov 11+ 1 more updateOrica Limited Provides Earnings Guidance for the Year 2024Orica Limited provided earnings guidance for the year 2024. The company’s 2024 financial year EBIT from continuing operations is expected to increase.
Reported Earnings • Nov 09Full year 2023 earnings released: EPS: AU$0.65 (vs AU$0.35 in FY 2022)Full year 2023 results: EPS: AU$0.65 (up from AU$0.35 in FY 2022). Revenue: AU$7.95b (up 12% from FY 2022). Net income: AU$295.7m (up 104% from FY 2022). Profit margin: 3.7% (up from 2.0% in FY 2022). Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 8.5% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
お知らせ • Nov 02CF Industries Files a Separate Lawsuit in the United States Against OricaOrica announced that it is a joint plaintiff in a lawsuit filed in the United States on 21 October 2023 (US time) against CF Industries regarding contractual disputes under an ammonium nitrate purchase agreement for the supply of ammonium nitrate and related products for use by Orica's business across North America. CF Industries filed a separate lawsuit in the United States regarding contractual disputes of this agreement on 22 October 2023 (US time). Orica is pursuing its claims and defending CF Industries' claims while continuing to fully comply with its contractual obligations.
Upcoming Dividend • May 18Upcoming dividend of AU$0.18 per share at 2.2% yieldEligible shareholders must have bought the stock before 25 May 2023. Payment date: 03 July 2023. Payout ratio is a comfortable 65% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of Australian dividend payers (7.3%). Lower than average of industry peers (5.7%).
お知らせ • May 13Orica Limited Announces Distribution for the Six Months Ended March 31, 2023, Payable on July 3, 2023Orica Limited announced the Distribution of AUD 0.18000000 per share for the six months ended March 31, 2023, payable on July 3, 2023. Record Date is on May 26, 2023 and Ex date is on May 25, 2023.
Reported Earnings • May 11First half 2023 earnings releasedFirst half 2023 results: EPS: AU$0.27. Revenue: AU$4.01b (up 31% from 1H 2022). Net income: AU$122.6m (up AU$122.6m from 1H 2022). Profit margin: 3.1% (up from 0% in 1H 2022). Revenue is forecast to stay flat during the next 3 years compared to a 11% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
お知らせ • Jan 18Orica Limited Announces Vanessa Guthrie AO as Independent, Non-Executive, Effective 1 February 2023Orica Limited announced the appointment of Dr. Vanessa Guthrie AO as independent, Non-Executive Director, to the Orica Board effective 1 February 2023. The appointment of Dr. Guthrie is part of the Orica Board's ongoing renewal process, following the retirement of Ms. Maxine Brenner and Mr. Boon Swan Foo at the conclusion of the 2022 Annual General Meeting and the previously announced appointment of Mr. Mark Garrett, effective 15 January 2023. Dr. Guthrie's broad and strategic experience in the resources sector started over 30 years ago in Australia with RGC Limited (Tasmania). Since then, Dr.Guthrie has held a diverse set of senior leadership roles across operations, environment, community, indigenous affairs and corporate development and sustainability. Previously Managing Director and CEO of ASX-listed Toro Energy Limited and private company Wellard Enterprises, Vice President Sustainable Development of Woodside Energy Limited, Huntly Mine Manager of Alcoa Australia and Chair of Minerals Council of Australia. Dr. Guthrie is Deputy Chair and Lead Independent Director of Adbri Limited, Non-Executive Director of Santos Limited, Tronox Holdings PLC and Lynas Rare Earths Limited, Non-Executive Director of Cricket Australia and Infrastructure Australia, and Pro-Chancellor of Curtin University. Dr. Guthrie's contribution to the mining and resources industry was recognised in 2017 with the award of an Honorary Doctor of Science from Curtin University. In 2021 she was also made an Officer of the Order of Australia. Dr. Guthrie is also a Fellow of the Australian Institute of Company Directors (FAICD), the Australian Academy of Technological Sciences and Engineering (FTSE) and the Australasian Institute of Mining and Metallurgy (FAusIMM). Dr. Guthrie has qualifications in geology, environment, law and business management, including a PhD in Geology.
お知らせ • Dec 23+ 2 more updatesOrica Limited, Annual General Meeting, Feb 13, 2023Orica Limited, Annual General Meeting, Feb 13, 2023.
Reported Earnings • Nov 10Full year 2022 earnings released: EPS: AU$0.35 (vs AU$0.46 loss in FY 2021)Full year 2022 results: EPS: AU$0.35 (up from AU$0.46 loss in FY 2021). Revenue: AU$7.13b (up 36% from FY 2021). Net income: AU$144.7m (up AU$333.1m from FY 2021). Profit margin: 2.0% (up from net loss in FY 2021). Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 7.1% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.
Upcoming Dividend • May 24Upcoming dividend of AU$0.13 per shareEligible shareholders must have bought the stock before 31 May 2022. Payment date: 08 July 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 1.5%. Lower than top quartile of Australian dividend payers (6.1%). Lower than average of industry peers (1.9%).
Reported Earnings • May 14First half 2022 earnings released: EPS: AU$0.002 (vs AU$0.18 in 1H 2021)First half 2022 results: EPS: AU$0.002 (down from AU$0.18 in 1H 2021). Revenue: AU$3.05b (up 26% from 1H 2021). Net income: AU$0 (down AU$73.7m from profit in 1H 2021). Profit margin: 0% (down from 3.0% in 1H 2021). Over the next year, revenue is forecast to grow 8.4%, compared to a 18% growth forecast for the industry in Australia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 90 percentage points per year, which is a significant difference in performance.
お知らせ • May 13Orica Limited Announces Distribution for the Period of Six Months Ended 31 March 2022, Payable on July 08, 2022Orica Limited announced the distribution of AUD 0.13000000 per share for the period of six months ended 31 March 2022. The dividend will paid on July 08, 2022 with record date of June 01, 2022 and ex-date is May 31, 2022.
お知らせ • Mar 28Orica Limited Appoints Gordon Naylor as Independent, Non-Executive Director, Effective 1 April 2022Orica Chairman Malcolm Broomhead announced the appointment of Mr. Gordon Naylor as independent, non-executive Director, effective 1 April 2022. Mr. Broomhead said that with Mr. Naylor's many years of global leadership experience at CSL, he will be a strong addition to the Board and complement the future strategy of the company. Mr. Naylor will offer himself for election as a Director at the next Annual General Meeting in December 2022. Starting his career as an engineer in the car manufacturing industry, Mr. Naylor then joined CSL, Australia's leading global biotech company. Over more than 30 years, Mr. Naylor held a range of business and functional leadership roles in international environments within CSL including as Chief Financial Officer for five years. At the time of his retirement from CSL, he was President of Seqirus where he had led the three-year turnaround of that business into the global influenza vaccines leader.
Buying Opportunity • Mar 23Now 20% undervaluedOver the last 90 days, the stock is up 12%. The fair value is estimated to be AU$19.23, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 2.8% per annum over the last 3 years. The company became loss making over the last year.
Recent Insider Transactions • Nov 17Independent Non-Executive Director recently bought AU$250k worth of stockOn the 15th of November, Boon Foo bought around 16k shares on-market at roughly AU$15.61 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$598k more in shares than they have sold in the last 12 months.
Reported Earnings • Nov 13Full year 2021 earnings releasedThe company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2021 results: Revenue: AU$5.25b (down 6.7% from FY 2020). Net loss: AU$188.4m (down 212% from profit in FY 2020).
Valuation Update With 7 Day Price Move • Oct 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to AU$14.01, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 32x in the Chemicals industry in Australia. Total loss to shareholders of 13% over the past three years.
Recent Insider Transactions • Oct 02Independent Non-Executive Director recently bought AU$137k worth of stockOn the 30th of September, Denise Gibson bought around 10k shares on-market at roughly AU$13.68 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$348k more in shares than they have sold in the last 12 months.
Upcoming Dividend • May 24Upcoming dividend of AU$0.075 per shareEligible shareholders must have bought the stock before 31 May 2021. Payment date: 09 July 2021. Trailing yield: 1.8%. Lower than top quartile of Australian dividend payers (5.2%). In line with average of industry peers (1.8%).
Reported Earnings • May 14First half 2021 earnings released: EPS AU$0.19 (vs AU$0.43 in 1H 2020)The company reported a poor first half result with weaker earnings, revenues and profit margins. First half 2021 results: Revenue: AU$2.64b (down 8.7% from 1H 2020). Net income: AU$76.7m (down 54% from 1H 2020). Profit margin: 2.9% (down from 5.7% in 1H 2020). Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
お知らせ • May 13Orica Declares Interim Dividend for the Six Ended March 31, 2021, Payable on 9 July 2021Orica Board has declared an interim dividend on ordinary shares of 7.5 cents per share, unfranked. The dividend represents a payout ratio (17) of 42%. The dividend is payable to shareholders on 9 July 2021 and shareholders registered as at the close of business on 1 June 2021 will be eligible for the interim dividend.
Executive Departure • Apr 09MD, CEO & Executive Director Alberto Zuleta has left the companyOn the 1st of April, Alberto Zuleta, was replaced as CEO by Sanjeev Gandhi. As of December 2020, Alberto personally held 268.40k shares (AU$4.1m worth at the time). A total of 2 executives have left over the last 12 months.
Is New 90 Day High Low • Feb 27New 90-day low: AU$12.56The company is down 25% from its price of AU$16.84 on 27 November 2020. The Australian market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$23.24 per share.
Valuation Update With 7 Day Price Move • Feb 27Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to AU$12.56, the stock is trading at a trailing P/E ratio of 29.5x, down from the previous P/E ratio of 35.2x. This compares to an average P/E of 30x in the Chemicals industry in Australia. Total return to shareholders over the past three years is a loss of 24%.
お知らせ • Feb 26+ 1 more updateOrica Limited Announces Executive ChangesOrica Chairman Malcolm Broomhead announced that Alberto Calderon will step down from his role as CEO, after almost six years in the role. Orica's Group Executive and President of Australia Pacific Asia, Sanjeev Gandhi, has been appointed as the new CEO of Orica Limited. Mr. Gandhi joined Orica in July 2020 after spending 26 years with German chemical company BASF SE, the global leader in the chemical industry. During his tenure with BASF, he held senior marketing, commercial, business leadership and director roles, in India, Germany, Japan, Singapore and Hong Kong. Most recently, Mr. Gandhi was an Executive Director of BASF SE and Head of Asia Pacific as well as Head of Global Chemicals Segment (Intermediates & Petrochemicals) based out of Hong Kong.
お知らせ • Jan 16Orica Limited, Annual General Meeting, Dec 16, 2021Orica Limited, Annual General Meeting, Dec 16, 2021.
Recent Insider Transactions • Jan 14MD, CEO & Executive Director recently bought AU$130k worth of stockOn the 14th of January, Alberto Zuleta bought around 7k shares on-market at roughly AU$18.87 per share. This was the largest purchase by an insider in the last 3 months. Alberto has been a buyer over the last 12 months, purchasing a net total of AU$211k worth in shares.
Is New 90 Day High Low • Jan 05New 90-day low: AU$14.92The company is down 10.0% from its price of AU$16.65 on 08 October 2020. The Australian market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$31.94 per share.
Recent Insider Transactions • Dec 01Non-Executive Director recently bought AU$61k worth of stockOn the 24th of November, John Beevers bought around 4k shares on-market at roughly AU$17.00 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$141k more in shares than they have sold in the last 12 months.
お知らせ • Nov 25+ 1 more updateOrica Limited to Report First Half, 2021 Results on May 13, 2021Orica Limited announced that they will report first half, 2021 results on May 13, 2021
Reported Earnings • Nov 21Full year 2020 earnings released: EPS AU$0.42The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: AU$5.63b (down 4.5% from FY 2019). Net income: AU$168.3m (down 31% from FY 2019). Profit margin: 3.0% (down from 4.2% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
Analyst Estimate Surprise Post Earnings • Nov 21Revenue misses expectationsRevenue missed analyst estimates by 1.0%. Over the next year, revenue is forecast to grow 3.0%, compared to a 2.7% growth forecast for the Chemicals industry in Australia.
Is New 90 Day High Low • Oct 31New 90-day low: AU$15.24The company is down 12% from its price of AU$17.29 on 31 July 2020. The Australian market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$26.66 per share.
Is New 90 Day High Low • Sep 22New 90-day low: AU$15.74The company is down 6.0% from its price of AU$16.79 on 24 June 2020. The Australian market is flat over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$22.09 per share.
